万春药业(BYSI)
icon
搜索文档
BeyondSpring(BYSI) - 2019 Q3 - Earnings Call Transcript
2019-12-19 00:30
BeyondSpring Inc. (NASDAQ:BYSI) Q3 2019 Earnings Conference Call December 18, 2019 8:00 AM ET Company Participants David Schemelia - Senior Vice President, KCSA Strategic Communications Lan Huang - Chairman and Chief Executive Officer Ramon Mohanlal - Executive Vice President of Research and Development and Chief Medical Officer Richard Daly - Chief Operating Officer Edward Liu - Chief Financial Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Andy Hsieh - William Blair Operator Good day ...
BeyondSpring(BYSI) - 2019 Q2 - Earnings Call Transcript
2019-09-19 03:05
BeyondSpring Inc. (NASDAQ:BYSI) Q2 2019 Earnings Conference Call September 18, 2019 8:00 AM ET Company Participants Stephen Kilmer - IR Lan Huang - Chairman & CEO Ramon Mohanlal - EVP of Research and Development and Chief Medical Officer Richard Daly - COO Edward Liu - CFO Conference Call Participants Andy Hsieh - William Blair Joe Pantginis - H.C. Wainwright Operator Good day everyone and welcome to BeyondSpring Inc's Second Quarter 2019 Financial Results Conference Call. My name is Melissa and I will be t ...
BeyondSpring(BYSI) - 2018 Q4 - Earnings Call Transcript
2019-05-06 02:20
BeyondSpring Inc. (NASDAQ:BYSI) Q4 2018 Results Earnings Conference Call April 30, 2019 8:00 AM ET Company Participants Stephen Kilmer - IR Lan Huang - Chairman and CEO Ramon Mohanlal - EVP of Research and Development and Chief Medical Officer Richard Daly - COO Edward Liu - CFO Conference Call Participants Operator Good day, everyone, and welcome to BeyondSpring Inc.'s Fourth Quarter and Full-Year 2018 Financial Results Conference Call. My name is Aerial, and I will be the operator on today's call. Please ...
BeyondSpring(BYSI) - 2018 Q4 - Annual Report
2019-05-01 04:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...